Improving Breast Cancer Therapy With CDK4/6 Inhibitors

被引：3
|
作者：
Jaganathan, Hamsa [1 ]
Overstreet, Karen [1 ]
Reed, Elizabeth [2 ]
机构：
[1] Imedex LLC, Med Affairs, Alpharetta, GA 30009 USA
[2] Univ Nebraska Med Ctr, Div Hematol & Oncol, Omaha, NE USA
来源：
CLINICAL BREAST CANCER | 2014年 / 14卷 / 06期
关键词：
D O I：
10.1016/j.clbc.2014.10.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：379 / 380
页数：2
相关论文
共 50 条
  • [41] Practice changing: CDK4/6 inhibitors in the adjuvant treatment of breast cancer
    Banys-Paluchowski, M.
    Paluchowski, Peter
    Krawczyk, Natalia
    [J]. ONKOLOGE, 2020, 26 (12): : 1167 - 1171
  • [42] Interstitial lung disease and CDK4/6 inhibitors in the treatment of breast cancer
    Schlam, Ilana
    Giordano, Antonio
    Tolaney, Sara M.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2023, 22 (12) : 1149 - 1156
  • [43] Recent progress of CDK4/6 inhibitors' current practice in breast cancer
    Wang, Xueqing
    Zhao, Shanshan
    Xin, Qinghan
    Zhang, Yunkun
    Wang, Kainan
    Li, Man
    [J]. CANCER GENE THERAPY, 2024,
  • [44] Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review
    Pandey, Kamal
    An, Hee-Jung
    Kim, Seung Ki
    Lee, Seung Ah
    Kim, Sewha
    Lim, Sun Min
    Kim, Gun Min
    Sohn, Joohyuk
    Moon, Yong Wha
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (05) : 1179 - 1188
  • [45] Recent advances of highly selective CDK4/6 inhibitors in breast cancer
    Xu, Hanxiao
    Yu, Shengnan
    Liu, Qian
    Yuan, Xun
    Mani, Sridhar
    Pestell, Richard G.
    Wu, Kongming
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 10
  • [46] Comparative overall survival of CDK4/6 inhibitors in combination with endocrine therapy in advanced breast cancer
    Coralea Kappel
    Mitchell J. Elliott
    Vikaash Kumar
    Michelle B. Nadler
    Alexandra Desnoyers
    Eitan Amir
    [J]. Scientific Reports, 14
  • [47] Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Kharenko, Olesya A.
    Patel, Reena G.
    Calosing, Cyrus
    van der Horst, Edward H.
    [J]. CANCER GENE THERAPY, 2022, 29 (06) : 859 - 869
  • [48] Combination of ZEN-3694 with CDK4/6 inhibitors reverses acquired resistance to CDK4/6 inhibitors in ER-positive breast cancer
    Olesya A. Kharenko
    Reena G. Patel
    Cyrus Calosing
    Edward H. van der Horst
    [J]. Cancer Gene Therapy, 2022, 29 : 859 - 869
  • [49] CDK4/6 Inhibitors in Cancer Therapy: A Novel Treatement Strategy for Bladder Cancer
    Pan, Qi
    Sathe, Anuja
    Black, Peter C.
    Goebell, Peter J.
    Kamat, Ashish M.
    Schmitz-Draeger, Bernd
    Nawroth, Roman
    [J]. BLADDER CANCER, 2017, 3 (02) : 79 - 88
  • [50] Treating cancer with selective CDK4/6 inhibitors
    Ben O'Leary
    Richard S. Finn
    Nicholas C. Turner
    [J]. Nature Reviews Clinical Oncology, 2016, 13 : 417 - 430
12345